Evogene (EVGN) Misses Q4 EPS by 5c

Evogene (NYSE: EVGN) reported Q4 EPS of ($0.22), $0.05 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.46 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance